Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Animal Therapeutics
 More »

  • VC Investment: Not Quite Dead?
    In the animal biotech category, one example of a Q1 financing was the March 7 disclosure of $10 million in financing from Square 1 Bank won by Aratana Therapeutics, a Kansas City ...
    5-15-2013
  • Human iPSC-Derived Hepatocytes
    as primary tissue isolates from human and animal donors that can be studied as intact ... limitations from development while focusing on safer and more in vivo-stable therapeutics. ...
    5-1-2013
  • Biosimilars: 10 Drugs to Watch
    ... studies as of 2012 BioXpress Therapeutics: Biosimilar in active development ... The iBioModulator has been shown in animal models to increase the strength and ...
    4-22-2013
  • ARMGO Gets $1M for Muscular Dystrophy Drug
    According to the company, Rycals have been shown in animal models of muscle disease to ... different way than the other potential therapeutics in development, which suggests that in ...
    4-17-2013
  • Exploring GPCRs as Therapeutic Targets
    ... which can in turn "inform translational animal models that may more directly mimic human ... with a synthetic antagonist. [Heptares Therapeutics] Heptares Therapeutics takes another ...
    4-15-2013
  • Advances in RNAi Tools and Technologies
    to be highly stable when injected into the bloodstream of animal models, he continues. ... of siRNAs in RNAi-mediated therapeutics, shRNAs are also important tools for ...
    4-15-2013
  • Single-Use Bioreactor Roundup
    ... applications such as the cultivation of animal and human cells in the biopharmaceutical ... the development of a new generation of therapeutics, the single-use bioreactor will be ...
    4-15-2013
  • Antibody Microarray Kit
    the discovery of novel diagnostics and therapeutics based on leading-edge knowledge of ... of many diverse proteins in human and animal cell and tissue specimens and features ...
    4-15-2013
  • Medicine: Getting Personal
    ... bovine serum and animal proteins are removed is whether the cells change in any fundamental way. Frederick Miesowicz, COO and vp of manufacturing at Argos Therapeutics, presented a ...
    3-15-2013
  • Genome Editing for R&D and Therapeutics
    ... Kayser. ZFN Therapeutics Translating technology to patient treatment is the ultimate goal ... has been used to correct a variety of congenital liver diseases in animal models. ...
    3-1-2013
  • Addressing Unmet Medical Needs with Complex Carbohydrate Chemistry
    Manchester, NH-based Boston Therapeutics developed this treatment under the name PAZ320 ... iron, targeting both human and animal tissues and organ systems deprived of ...
    2-28-2013
  • People in the News
    A. Stephanus Aratana Therapeutics added Julia A. Stephanus as CCO. Prior to joining Aratana, Stephanus was director of the Companion Animal Global Franchise at Ceva Animal Health. ...
    2-15-2013
  • Plant-Based Protein Biomanufacturing
    ... background organism that does not harbor animal contaminants or human pathogens would ... that plant-manufactured protein therapeutics can successfully be taken through the ...
    2-15-2013
  • Next-Generation Sequencing in the Clinic
    ... has changed, and what new therapeutics might be applicable to treating their disease. ... parsed out to different labs using different model animal systems, human cell lines, etc. ...
    2-13-2013
  • Top 10 VC & Biopharma Equity Deals of 2012
    ... UltraVector is the backbone of Intrexon's activities in human healthcare, animal science, ... North and South America. #1. Intarcia Therapeutics Equity invested: $155.9 million 10 ...
    2-8-2013
  • More »

    Journal Articles

  • Bone Tissue Engineering and Regeneration: From Discovery to the...
    Regis J. O'Keefe, Jeremy Mao
    Tissue Engineering, Part B: Reviews
    Although in vitro and preclinical animal studies have been pursued with a large and ... and strategies for translation of fundamental discoveries into clinical therapeutics.
  • Rapid Large-Scale Expansion of Functional Mesenchymal Stem Cells...
    Katharina Schallmoser, Eva Rohde, Andreas Reinisch, Christina Bartmann, Daniela Thaler, Camilla Drexler, Anna C. Obenauf, Gerhard Lanzer, Werner Linkesch, Dirk Strunk
    Tissue Engineering, Part C: Methods
    procedure can build the basis for standardized manufacturing of MSC-based therapeutics under animal serum-free conditions for dose-escalated cellular therapy and tissue ...
  • Comparison of Immunopathology and Locomotor Recovery in C57BL...
    Sabina Luchetti, Kevin D. Beck, Manuel D. Galvan, Richard Silva, Brian J. Cummings, Aileen J. Anderson
    Journal of Neurotrauma
    Journal of Neurotrauma Abstract Studies of cell transplantation therapeutics in animal models of traumatic spinal cord injury (SCI) are often hampered by partial or complete ...
  • Animal Models for the Mechanistic Study of Systemic Lymphangiomatosis
    Stanley G. Rockson
    Lymphatic Research and Biology
    considered within the context of the animal models that have produced evolving insights. ... to investigate new and emerging therapeutics for the often devastating disease of ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll